Biovica (Sweden)

Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib

Nusayba A. Bagegni, Shana Thomas, Ning Liu et al. · Breast Cancer Research · 2017 · 68 citations · Full text

Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy

Martina Bonechi, Francesca Galardi, Chiara Biagioni et al. · Oncotarget · 2018 · 47 citations · Full text

Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor–positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)

Amelia McCartney, Chiara Biagioni, Gaia Schiavon et al. · European Journal of Cancer · 2019 · 40 citations

Breast Oncology, Prognostic Role, Medicine +8

Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial

Judith Bjöhle, Jenny Bergqvist, J. Simon Gronowitz et al. · Breast Cancer Research and Treatment · 2013 · 39 citations

Metastatic Breast Cancer, Breast Oncology, Medicine +8

Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer

Anna-Maria Larsson, Pär‐Ola Bendahl, Kristina Aaltonen et al. · Scientific Reports · 2020 · 34 citations · Full text